Business Description
Guardion Health Sciences Inc
NAICS : 325412
SIC : 2833
ISIN : US40145Q5009
Description
Guardion Health Sciences Inc clinical nutrition company that develops and distributes clinically supported dietary supplements and medical foods. It offers a portfolio of science-based, clinically supported products designed to support consumers, healthcare professionals and providers, and their patients by supporting bone health, eye health, cardiovascular health, and brain health through nutrients such as Calcium, Vitamin D, Vitamin K, Carotenoids, and Omega-3s.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.9 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.33 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.3 | |||||
| 3-Year EBITDA Growth Rate | 52.8 | |||||
| 3-Year EPS without NRI Growth Rate | 54.5 | |||||
| 3-Year FCF Growth Rate | 50.4 | |||||
| 3-Year Book Growth Rate | -38.9 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.34 | |||||
| 9-Day RSI | 65.01 | |||||
| 14-Day RSI | 64.93 | |||||
| 6-1 Month Momentum % | 15.42 | |||||
| 12-1 Month Momentum % | 23.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 16.68 | |||||
| Quick Ratio | 16.59 | |||||
| Cash Ratio | 16.16 | |||||
| Days Inventory | 135.18 | |||||
| Days Sales Outstanding | 60.23 | |||||
| Days Payable | 41.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward Dividend Yield % | 156.04 | |||||
| 3-Year Average Share Buyback Ratio | -61.4 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 43.07 | |||||
| Operating Margin % | -41.23 | |||||
| Net Margin % | 68.21 | |||||
| FCF Margin % | -41.94 | |||||
| ROE % | 79.19 | |||||
| ROA % | 49.82 | |||||
| ROIC % | -126.39 | |||||
| ROC (Joel Greenblatt) % | -131.26 | |||||
| ROCE % | -33.77 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 2.59 | |||||
| Price-to-Owner-Earnings | 2.47 | |||||
| PS Ratio | 1.73 | |||||
| PB Ratio | 1.2 | |||||
| Price-to-Tangible-Book | 1.2 | |||||
| EV-to-EBIT | -3.32 | |||||
| EV-to-EBITDA | -3.33 | |||||
| EV-to-Revenue | 1.37 | |||||
| EV-to-FCF | -4.52 | |||||
| Price-to-Net-Current-Asset-Value | 1.2 | |||||
| Price-to-Net-Cash | 1.24 | |||||
| Earnings Yield (Greenblatt) % | -30.12 | |||||
| FCF Yield % | -23.81 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers